Viroactiv® HPV antibodies have been developed for HPV screening and typing. With Viroactiv HPV antibodies, immunohistochemical detection allows routine morphologic evaluation with the recognition and typing of HPV protein in formalin-fixed, paraffin-embedded tissue sections, and in cytological specimens (native, Pap-stained, cervical swabs of monolayer slides).
     The new antibodies include monoclonal mouse anti-HPV for HPV screening, mouse anti-HPV high risk (HPV 16, 18, 33, 35, 39, 45, 56, 58) for HPV high-risk screening, and mouse anti-HPV 16/18, anti-HPV 16, and anti-HPV 18 for HPV typing.
     Viroactiv HPV antibodies are for in vitro diagnostic use and can be paired with PicTure® polymer detection systems.

Zymed Laboratories Inc
(650) 871-4494;